FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to oral antituberculous agents. The given agent is presented in the form of an enteric-coated granule and contains: sodium para-aminosalicylate - 500 to 900 mg; isoniaside 19 to 26 mg; hydrogenated vegetable oil - 1.1-1.5 mg; crospovidone - 22-31 mg; sodium disulphite - 4-12 mg; methylcellulose - 11-19 mg with a granule density varying within 0.9 to 1.05 g/ml, a enteric coating thickness making 0.2-0.3 mm, a particle size of isoniaside falling within the range that is 2-3 higher than that of sodium para-aminosalicylate, while a particle size of crospovidone is 2-3 times higher than those of sodium para-aminosalicylate and sodium disulphite. All particles of the active ingredients are uniformly distributed throughout the granule.
EFFECT: reducing the toxic effect of para-aminosalicylate on the human body.
14 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-TUBERCULOSIS MEDICATION | 2010 |
|
RU2424809C1 |
ANTITUBERCULAR COMPOSITION COMPRISING RIFAMPICIN, ISONIAZID, ETHAMBUTOL AND PYRAZINAMIDE AND PROCESS FOR PREPARATION THEREOF | 2014 |
|
RU2672879C2 |
PHARMACEUTICAL COMPOSITIONS OF ANTITUBERCULOSIS MEDICINAL AGENTS AND METHOD FOR THEIR PREPARING | 2001 |
|
RU2240795C9 |
ANTITUBERCULOUS DRUG AND METHOD OF TREATING | 2010 |
|
RU2449797C1 |
ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN FORM OF DISPERSIBLE TABLET CONTAINING GRANULATED ISONIAZID AND GRANULATED RIFAPENTINE, AND METHOD FOR PREPARING IT | 2014 |
|
RU2694056C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION | 2014 |
|
RU2682178C2 |
ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
Authors
Dates
2013-11-20—Published
2012-07-31—Filed